Latest Masimo Stories

IRVINE, Calif., July 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in Respiratory Physiology & Neurobiology shows that noninvasive carboxyhemoglobin (SpCO®) and methemoglobin (SpMet®) measurements with Masimo rainbow® Pulse CO-Oximetry(TM) are accurate and conclude they can be used as an effective first screening test with emergency room patients suspected of suffering carbon monoxide (CO) poisoning.(1) CO poisoning is a major cause of morbidity and...

IRVINE, Calif., July 3, 2012 /PRNewswire/ -- The U.S. Department of Defense Military Health System has selected the Masimo Rad-57(TM) Handheld Pulse CO-Oximeter as the military's standardized handheld pulse oximeter for use worldwide, Masimo (NASDAQ: MASI) announced today. This agreement is available to all designated Medical Treatment Facilities and Operational Field Units across the Department of Defense's global healthcare system, from first responders to definitive care. The...

IRVINE, Calif., July 2, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that PSS World Medical, Inc., (NASDAQ: PSSI) a leading national distributor of medical supplies and equipment to office-based physicians, will distribute the new Pronto-7(TM) - a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo: http://photos.prnewswire.com/prnh/20110808/LA46231) Pronto-7...

IRVINE, Calif., June 25, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in the Journal of Clinical Anesthesia demonstrates the Masimo Radical(R) with Masimo SET(R) pulse oximetry had higher oxygen saturation (SpO2) specificity and sensitivity and lower failure rates during conditions of motion and low perfusion than other "new-generation" pulse oximeters.(1) Monitoring of SpO2 enables clinicians to detect hypoxemia (deficient blood oxygen) at an early stage....

IRVINE, Calif., June 21, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in The American Journal of Emergency Medicine demonstrates for the first time that compared to invasive carboxyhemoglobin (COHb) measurement with laboratory CO-oximetry, noninvasive carboxyhemoglobin (SpCO®) measurement with Masimo rainbow® Pulse CO-Oximetry(TM) leads to more rapid diagnosis of carbon monoxide (CO) poisoning and a shorter time to the initiation of treatment with...

OTTAWA, Ontario, June 19, 2012 /PRNewswire/ -- Kinaxis®, provider of RapidResponse®, a cloud-based solution at the heart of planning and response management for value chain operations, today announced that Masimo Corporation, a leading medical device provider, has deployed Kinaxis RapidResponse as its core planning and analytics engine. (Logo: http://photos.prnewswire.com/prnh/20120208/CG49456LOGO-b) Masimo develops and manufactures noninvasive patient monitoring technologies....

IRVINE, Calif., June 18, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that a follow-up analysis appearing in the Spring-Summer 2012 issue of the Anesthesia Patient Safety Foundation newsletter demonstrated that implementing Masimo SET Measure-through Motion and Low Perfusion pulse oximetry and the Masimo Patient SafetyNet((TM)) remote monitoring and clinician notification system in all post-surgical, general floor units at Dartmouth Hitchcock Medical Center resulted...

IRVINE, Calif., June 13, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that Henry Schein Medical, the Medical business of Henry Schein, Inc., (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based practitioners, will distribute the new Pronto-7(TM) - a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo:...

LONDON, June 11, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today the National Health Service Technology Adoption Centre in the United Kingdom is advising hospitals to use Intraoperative Fluid Management Technologies as a way to improve patient outcomes, and included Masimo's noninvasive and continuous Pleth Variability Index (PVI®) among technologies available for helping clinicians manage fluid during surgeries. "The use of Intraoperative Fluid Management...

IRVINE, Calif., June 8, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) CEO and founder Joe Kiani received the Ernst & Young (Orange County) Entrepreneur of the Year® Award during a gala at the St. Regis Monarch Beach Resort in Dana Point, Calif., Thursday evening. Kiani is an inventor of pioneering noninvasive patient-monitoring devices, a trusted voice for patient safety and care, and a convention-breaking maverick. Founded in 1989, Masimo has grown from a garage startup into...